Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07569757
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple MyelomaChia Tai Tianqing Pharmaceutical Group Co., Ltd.Not Yet RecruitingPhase 3
NCT07569757Not Yet Recruiting
Phase 3
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple MyelomaChia Tai Tianqing Pharmac...
NCT07568795
Clinical Validation of Portable Electronic Stethoscope for Detecting VHDThe University of Hong KongRecruiting
NCT07568795Recruiting
—
Clinical Validation of Portable Electronic Stethoscope for Detecting VHDThe University of Hong Ko...
NCT07569614
Comparative Effects of Remimazolam Tosylate and Dexmedetomidine on Postoperative Delirium in Elderly Patients Undergoing Thoracoscopic Surgery.First Affiliated Hospital of Kunming Medical UniversityCompletedNot Applicable
NCT07569614Completed
Not Applicable
Comparative Effects of Remimazolam Tosylate and Dexmedetomidine on Postoperative...First Affiliated Hospital...
NCT07569211
Simplified HCV Integrated Management Model in Methadone Clinics in UkraineThe Western-Eastern European Partnership Initiative on HIV, Viral Hepatitis and TBCompletedNot Applicable
NCT07569211Completed
Not Applicable
Simplified HCV Integrated Management Model in Methadone Clinics in UkraineThe Western-Eastern Europ...
NCT07570888
This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycophenolate Across a Wide Variety of Pulmonary Fibrosis Subtypes, With the Aim of Providing Clinicians With Assurance That This is an Appropriate Therapeutic Combination.Boehringer IngelheimNot Yet RecruitingPhase 4
NCT07570888Not Yet Recruiting
Phase 4
This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycop...Boehringer Ingelheim
NCT07569627
Effects of BFR-training on Stem Cells and Immune Cells in Human Skeletal MuscleUniversity of TaipeiCompletedNot Applicable
NCT07569627Completed
Not Applicable
Effects of BFR-training on Stem Cells and Immune Cells in Human Skeletal MuscleUniversity of Taipei
NCT07570862
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus NephritisFate TherapeuticsNot Yet RecruitingPhase 2
NCT07570862Not Yet Recruiting
Phase 2
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Neph...Fate Therapeutics
NCT07571551
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell CarcinomaJinling Hospital, ChinaNot Yet RecruitingPhase 2
NCT07571551Not Yet Recruiting
Phase 2
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell CarcinomaJinling Hospital, China
NCT07569835
Clinical and Radiological Evaluation Over 10 Years After Bilateral Subtalar Arthrorisis Surgery With Endorthesis and Calcaneal Stop for the Correction of Pediatric FlatfootIstituto Ortopedico RizzoliRecruiting
NCT07569835Recruiting
—
Clinical and Radiological Evaluation Over 10 Years After Bilateral Subtalar Arth...Istituto Ortopedico Rizzo...
NCT07570147
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult ParticipantsAbbVieNot Yet RecruitingPhase 1
NCT07570147Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Asc...AbbVie
NCT07571824
A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy SubjectsCorium Innovations, Inc.RecruitingPhase 1
NCT07571824Recruiting
Phase 1
A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy...Corium Innovations, Inc.
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07569133
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's DiseaseHo-Won LeeEnrolling By InvitationNot Applicable
NCT07569133Enrolling By Invitation
Not Applicable
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressiv...Ho-Won Lee
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07569328
Low-dose Colchicine for CABG Graft Failure PreventionBeijing Anzhen HospitalNot Yet RecruitingNot Applicable
NCT07569328Not Yet Recruiting
Not Applicable
Low-dose Colchicine for CABG Graft Failure PreventionBeijing Anzhen Hospital
NCT07570836
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan HospitalNot Yet RecruitingPhase 1
NCT07570836Not Yet Recruiting
Phase 1
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan Hospit...
NCT07571291
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSISFondazione IRCCS Policlinico San Matteo di PaviaActive Not Recruiting
NCT07571291Active Not Recruiting
—
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF I...Fondazione IRCCS Policlin...
NCT07569068
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ AdenocarcinomaRuijin HospitalRecruitingPhase 2
NCT07569068Recruiting
Phase 2
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Posit...Ruijin Hospital
NCT07571473
CoreSys Monitoring for Intraoperative Stress Management in Abdominal HysterectomyCoresys HealthRecruitingNot Applicable
NCT07571473Recruiting
Not Applicable
CoreSys Monitoring for Intraoperative Stress Management in Abdominal Hysterectom...Coresys Health
Result Breakdown
Not yet recruiting7 (35%)
Recruiting7 (35%)
Completed3 (15%)
Enrolling by invitation2 (10%)
Active, not recruiting1 (5%)
not_applicable8 (40%)
Phase 24 (20%)
Not Specified3 (15%)
Phase 13 (15%)
Phase 31 (5%)
Phase 41 (5%)